| scholarly article | Q13442814 |
| P50 | author | Robert Dantzer | Q3434896 |
| Lucile Capuron | Q58756293 | ||
| Sophie Layé | Q61783696 | ||
| P2093 | author name string | Annemieke Kavelaars | |
| Cobi Johanna Heijnen | |||
| P2860 | cites work | Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease | Q24202648 |
| Exercise for the management of cancer-related fatigue in adults | Q24202860 | ||
| Interventions for fatigue and weight loss in adults with advanced progressive illness | Q24203914 | ||
| From inflammation to sickness and depression: when the immune system subjugates the brain | Q24633527 | ||
| Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior | Q28508390 | ||
| How do you feel--now? The anterior insula and human awareness | Q29547250 | ||
| The role of the basal ganglia in habit formation | Q29619829 | ||
| Ascending caudal medullary catecholamine pathways drive sickness-induced deficits in exploratory behavior: Brain substrates for fatigue? | Q30428032 | ||
| Lipopolysaccharide challenge-induced suppression of Fos in hypothalamic orexin neurons: their potential role in sickness behavior | Q30434609 | ||
| The noradrenergic symptom cluster: clinical expression and neuropharmacology | Q30474844 | ||
| Functional neuroimaging of fatigue | Q33434242 | ||
| Physical activity and fatigue in breast cancer and multiple sclerosis: psychosocial mechanisms | Q33671860 | ||
| How (and why) the immune system makes us sleep. | Q33731135 | ||
| Cortical and basal ganglia contributions to habit learning and automaticity | Q33823748 | ||
| The potential of minocycline for neuroprotection in human neurologic disease | Q33983971 | ||
| Biological basis of the behavior of sick animals | Q34048744 | ||
| Fatigue and basal ganglia | Q34071789 | ||
| Cytokine-induced sickness behaviour: mechanisms and implications | Q34114821 | ||
| Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown | Q34277561 | ||
| Fatigue in neurological disorders | Q34308653 | ||
| Inflammation and fatigue dimensions in advanced cancer patients and cancer survivors: an explorative study | Q34317938 | ||
| Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide | Q34478106 | ||
| Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward | Q34514025 | ||
| Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. | Q34655648 | ||
| Toward the future of psychiatric diagnosis: the seven pillars of RDoC | Q34721927 | ||
| Immune system to brain signaling: neuropsychopharmacological implications. | Q34769827 | ||
| The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration. | Q34786812 | ||
| The psychology of doing nothing: forms of decision avoidance result from reason and emotion | Q35055874 | ||
| Dopamine and effort-based decision making | Q35064882 | ||
| Molecular insights on the cerebral innate immune system | Q35077014 | ||
| Inflammation-induced lethargy is mediated by suppression of orexin neuron activity | Q35163129 | ||
| Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task | Q35746360 | ||
| A systematic review of the association between immunogenomic markers and cancer-related fatigue | Q36098741 | ||
| Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? | Q36226201 | ||
| Regulation of inflammation and redox signaling by dietary polyphenols | Q36571463 | ||
| Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration | Q36806349 | ||
| Patient-reported outcomes measurement information system (PROMIS) domain names and definitions revisions: further evaluation of content validity in IRT-derived item banks | Q36896785 | ||
| A systematic review of patient-reported measures of burden of treatment in three chronic diseases | Q36975806 | ||
| NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice | Q37030206 | ||
| Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia | Q37062269 | ||
| Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer | Q37087117 | ||
| Using the common sense model to design interventions for the prevention and management of chronic illness threats: from description to process | Q37106721 | ||
| Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates | Q37172720 | ||
| Immune-to-brain signaling: how important are the blood-brain barrier-independent pathways? | Q37194695 | ||
| Chronic immune stimulation correlates with reduced phenylalanine turnover | Q37264638 | ||
| Physical and mental fatigue in Parkinson's disease: epidemiology, pathophysiology and treatment | Q37439853 | ||
| The blood-brain barrier and immune function and dysfunction | Q37576216 | ||
| Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications | Q37688991 | ||
| The central role of cognitive processes in the perpetuation of chronic fatigue syndrome | Q37733877 | ||
| Central fatigue: issues related to cognition, mood and behavior, and psychiatric diagnoses | Q37775388 | ||
| Biochemical and anatomical substrates of depression and sickness behavior | Q37777928 | ||
| Significance of the insula for the evolution of human awareness of feelings from the body | Q37870955 | ||
| Fatty acids and inflammation: the cutting edge between food and pharma. | Q37911577 | ||
| Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry | Q37966506 | ||
| Neuroinflammation in Parkinson's disease. | Q37968058 | ||
| The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond | Q37979784 | ||
| Neural circuitry engaged by prostaglandins during the sickness syndrome | Q38029970 | ||
| From the ventral to the dorsal striatum: devolving views of their roles in drug addiction | Q38084446 | ||
| Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. | Q38410039 | ||
| Health promotion by social cognitive means | Q39513139 | ||
| Symptoms in hospitalized patients: outcome and satisfaction with care | Q39522895 | ||
| Endotoxin-induced appearance of immunoreactive interleukin-1β in ramified microglia in rat brain: A light and electron microscopic study | Q40687142 | ||
| Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. | Q40711383 | ||
| Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction? | Q40824259 | ||
| Neural origins of human sickness in interoceptive responses to inflammation | Q41061255 | ||
| Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system | Q42502064 | ||
| Advanced Parkinson's disease effect on goal-directed and habitual processes involved in visuomotor associative learning | Q43102363 | ||
| Fatigue and chronic fatigue syndrome-like complaints in the general population | Q43290099 | ||
| Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. | Q43942974 | ||
| Deployment-related severe fatigue with depressive symptoms is associated with increased glucocorticoid binding to peripheral blood mononuclear cells. | Q45918617 | ||
| Human insula activation reflects risk prediction errors as well as risk. | Q46410414 | ||
| Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents | Q48148757 | ||
| Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. | Q48156928 | ||
| Insula and striatum mediate the default bias | Q48174144 | ||
| A common role of insula in feelings, empathy and uncertainty | Q48498468 | ||
| Effects of interleukin-1beta on food-maintained behavior in the mouse | Q48561488 | ||
| Differential effects of lipopolysaccharide on pup retrieving and nest building in lactating mice | Q48686303 | ||
| Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study | Q48695940 | ||
| Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. | Q52031981 | ||
| The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system | Q58302057 | ||
| Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice | Q60777374 | ||
| An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia | Q73263703 | ||
| Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia | Q74139800 | ||
| Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritis | Q80442324 | ||
| Interactions between the immune and neuroendocrine systems | Q84241962 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 39-46 | |
| P577 | publication date | 2013-11-13 | |
| P1433 | published in | Trends in Neurosciences | Q3538443 |
| P1476 | title | The neuroimmune basis of fatigue | |
| P478 | volume | 37 |
| Q38789683 | Allostatic Self-efficacy: A Metacognitive Theory of Dyshomeostasis-Induced Fatigue and Depression |
| Q58188338 | Altered neural signatures of interoception in multiple sclerosis |
| Q52108659 | An active inference theory of allostasis and interoception in depression. |
| Q58588055 | Anhedonia in cocaine use disorder is associated with inflammatory gene expression |
| Q92132111 | Association between fatigue, motivational measures (BIS/BAS) and semi-structured psychosocial interview in hemodialytic treatment |
| Q26801476 | Behavioral Symptoms after Breast Cancer Treatment: A Biobehavioral Approach |
| Q40697506 | Conventional treatment regimens for ulcerative colitis alleviate fatigue - an observational cohort study |
| Q38820931 | Disease-Induced Skeletal Muscle Atrophy and Fatigue. |
| Q98245601 | Disentangling fatigue from anhedonia: a scoping review |
| Q89736245 | Diurnal Cortisol Secretion Is Not Related to Multiple Sclerosis-Related Fatigue |
| Q58769302 | Drive in Sports: How Mental Fatigue Affects Endurance Performance |
| Q36530043 | Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder |
| Q47318811 | Effort but not Reward Sensitivity is Altered by Acute Sickness Induced by Experimental Endotoxemia in Humans |
| Q28077400 | Examining techniques for measuring the effects of nutrients on mental performance and mood state |
| Q47364349 | Exercise is an effective treatment for positive valence symptoms in major depression |
| Q36584878 | Exercise, inflammation, and fatigue in cancer survivors |
| Q38815010 | Exploratory Investigation of Early Biomarkers for Chronic Fatigue in Prostate Cancer Patients Following Radiation Therapy. |
| Q47550497 | Fatigue in Patients with Major Depressive Disorder: Prevalence, Burden and Pharmacological Approaches to Management. |
| Q26782282 | Fatigue in chronic inflammation - a link to pain pathways |
| Q38953121 | Fatigue in kidney transplant recipients |
| Q88575375 | Fatigue is associated with high prevalence and severity of physical and emotional symptoms in patients on chronic hemodialysis |
| Q57826416 | Fatigue is common and severe in patients with mastocytosis |
| Q48062782 | Fatigue predicts disease worsening in relapsing-remitting multiple sclerosis patients |
| Q92857748 | Fatigue, Sleep, and Autoimmune and Related Disorders |
| Q38748748 | Health care utilization among young Australian women with severe tiredness: Results from the Australian Longitudinal Study on Women's Health (ALSWH). |
| Q36719483 | Heat shock proteins and chronic fatigue in primary Sjögren's syndrome |
| Q90634291 | Heat-shock protein 90α in plasma reflects severity of fatigue in patients with Crohn's disease |
| Q35808109 | Increased Th17/Treg Ratio in Poststroke Fatigue |
| Q90176765 | Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer |
| Q36628292 | Inflammation-induced pain sensitization in men and women: does sex matter in experimental endotoxemia? |
| Q46893422 | Inflammatory pathway genes associated with inter-individual variability in the trajectories of morning and evening fatigue in patients receiving chemotherapy. |
| Q91763412 | Influence of combined functional resistance and endurance exercise over 12 weeks on matrix metalloproteinase-2 serum concentration in persons with relapsing-remitting multiple sclerosis - a community-based randomized controlled trial |
| Q64052682 | Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sjögren’s syndrome |
| Q26999472 | Interoceptive predictions in the brain |
| Q35681891 | Investigating neural mechanisms of change of cognitive behavioural therapy for chronic fatigue syndrome: a randomized controlled trial |
| Q28260126 | Is it time to turn our attention toward central mechanisms for post-exertional recovery strategies and performance? |
| Q37695333 | Lifetime Modulation of the Pain System via Neuroimmune and Neuroendocrine Interactions. |
| Q47399817 | Lipopolysaccharide Alters Motivated Behavior in a Monetary Reward Task: a Randomized Trial |
| Q40500968 | Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis. |
| Q30251615 | Mastocytosis in adulthood and neuropsychiatric disorders |
| Q26998870 | Mechanisms of chemotherapy-induced behavioral toxicities |
| Q91622821 | Modafinil treatment modulates functional connectivity in stroke survivors with severe fatigue |
| Q61449541 | Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods |
| Q92737059 | No structural cerebral MRI changes related to fatigue in patients with primary Sjögren's syndrome |
| Q36332581 | Normative data on the diurnal pattern of the Karolinska Sleepiness Scale ratings and its relation to age, sex, work, stress, sleep quality and sickness absence/illness in a large sample of daytime workers |
| Q47946388 | On the relation between self-reported cognitive fatigue and the posterior hypothalamic-brainstem network |
| Q34156977 | Osteosarcopenic obesity: the role of bone, muscle, and fat on health |
| Q38621244 | Pain may be an important factor to consider in inflammatory bowel disease patients troubled by fatigue |
| Q38513417 | Participation of α2 -adrenoceptors in sodium appetite inhibition during sickness behaviour following administration of lipopolysaccharide |
| Q64029447 | Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis |
| Q61804578 | Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome |
| Q38710377 | Postdialysis Fatigue: A Frequent and Debilitating Symptom |
| Q50882670 | Probiotics Improve Inflammation-Associated Sickness Behavior by Altering Communication between the Peripheral Immune System and the Brain. |
| Q42680757 | Relationship of Objectively-Measured Habitual Physical Activity to Chronic Inflammation and Fatigue in Middle-Aged and Older Adults |
| Q37595009 | Role of Inflammation in Human Fatigue: Relevance of Multidimensional Assessments and Potential Neuronal Mechanisms. |
| Q38843536 | Role of Inflammation in the Development of Neuropsychiatric Symptom Domains: Evidence and Mechanisms. |
| Q59825139 | Sex differences in how inflammation affects behavior: What we can learn from experimental inflammatory models in humans |
| Q36302366 | Sickness behavior in feverish children is independent of the severity of fever. An observational, multicenter study |
| Q37532929 | Social Phobia Is Associated with Delayed Onset of Chickenpox, Measles, and Mumps Infections. |
| Q55383738 | The High Costs of Low-Grade Inflammation: Persistent Fatigue as a Consequence of Reduced Cellular-Energy Availability and Non-adaptive Energy Expenditure. |
| Q92670282 | The Sleep-Immune Crosstalk in Health and Disease |
| Q64988125 | The Virtual Personalities Neural Network Model: Neurobiological Underpinnings. |
| Q90907891 | The association of fatigue with dispositional mindfulness: relationships by levels of depressive symptoms, sleep quality, childhood adversity, and chronic medical conditions |
| Q30917626 | The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders |
| Q90210608 | The neuroscience of vision and pain: evolution of two disciplines |
| Q89366098 | The pathophysiology of cancer-related fatigue: current controversies |
| Q38356502 | The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment. |
| Q34677503 | The representation of inflammatory signals in the brain - a model for subjective fatigue in multiple sclerosis |
| Q87671063 | The role of TRAIL in fatigue induced by repeated stress from radiotherapy |
| Q57159746 | The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation |
| Q90850805 | The role of neuro-immune interactions in cancer-related fatigue: Biobehavioral risk factors and mechanisms |
| Q30394702 | The theory of constructed emotion: an active inference account of interoception and categorization |
| Q99731888 | Toll-like receptor 4 mediates the development of fatigue in the murine Lewis Lung Carcinoma model independently of activation of macrophages and microglia |
| Q55261484 | mGluR5 mediates post-radiotherapy fatigue development in cancer patients. |
Search more.